Comment on CMS-2026-1255-0001

Summary: Blood Cancer United, an advocacy organization representing patients and families, supports the proposed rule to extend electronic prior authorization standards to prescription drugs and the small group market. They argue that these measures are essential for reducing treatment delays and advocate for additional protections like shorter response timeframes, public data transparency, and continuity-of-care protections.